Table 1. Patient characteristics.
Variable | Category | Total | Relapsed | Relapse-free | P-value |
---|---|---|---|---|---|
Training set – SCC | |||||
|
|
n=50 (100%) |
n=20 (100%) |
n=30 (100%) |
|
Sex | Male | 39 (78) | 17 (85) | 22 (73) | 0.53 |
|
Female |
11 (22) |
3 (15) |
8 (27) |
|
Stage | IA | 6 (12) | 0 (0) | 6 (20) | 0.08 |
IB | 25 (50) | 11 (55) | 14 (47) | ||
IIA | 0 (0) | 0 (0) | 0 (0) | ||
IIB | 17 (34) | 9 (45) | 8 (27) | ||
|
IIIA |
2 (4) |
0 (0) |
2 (7) |
|
Grade | G1 | 4 (8) | 2 (10) | 2 (7) | 0.65 |
G2 | 34 (68) | 12 (60) | 22 (73) | ||
|
G3 |
12 (24) |
6 (30) |
6 (20) |
|
Mean age (range) |
|
67 (48–77) |
63 (48–75) |
68 (49–77) |
0.38 |
Confirmatory set – SCC | |||||
|
|
n=134 (100%) |
n=54 (100%) |
n=80 (100%) |
|
Sex | Male | 101 (75) | 39 (72) | 62 (77) | 0.55 |
|
Female |
33 (25) |
15 (28) |
18 (23) |
|
Stage | IA | 29 (22) | 5 (9) | 24 (30) | 0.034 |
IB | 65 (48) | 25 (46) | 40 (50) | ||
IIA | 4 (3) | 1 (2) | 3 (4) | ||
IIB | 31 (23) | 20 (37) | 11 (14) | ||
|
IIIA |
5 (4) |
3 (6) |
2 (2) |
|
Grade | G1 | 5 (4) | 2 (4) | 3 (4) | 0.52 |
G2 | 78 (58) | 29 (54) | 49 (61) | ||
|
G3 |
51 (38) |
23 (42) |
28 (35) |
|
Mean age (range) |
|
64 (39–81) |
62 (39–79) |
64 (47–81) |
0.033 |
AC | |||||
|
|
n=89 (100%) |
n=35 (100%) |
n=54 (100%) |
|
Sex | Male | 57 (64) | 24 (69) | 33 (61) | 0.62 |
|
Female |
32 (36) |
11 (31) |
21 (39) |
|
Stage | IA | 28 (31) | 7 (20) | 21 (39) | 0.093 |
IB | 34 (38) | 12 (34) | 22 (41) | ||
IIA | 3 (3) | 2 (6) | 1 (2) | ||
IIB | 23 (26) | 13 (37) | 10 (18) | ||
|
IIIA |
1 (1) |
1 (3) |
0 (0) |
|
Predominant histological type | Acinar | 34 (38) | 18 (51) | 16 (30) | 0.31 |
Solid | 30 (34) | 10 (29) | 20 (37) | ||
Papillary | 7 (8) | 3 (8) | 4 (7) | ||
Micro-papillary | 3 (3) | 1 (3) | 2 (4) | ||
Lepidic | 8 (9) | 1 (3) | 7 (13) | ||
|
Mucinous |
7 (8) |
2 (6) |
5 (9) |
|
Mean age (range) | 61 (45–81) | 61 (45–81) | 61 (46–75) | 0.46 |
Abbreviations: AC=adenocarcinoma; SCC=squamous cell carcinoma.